FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
116,364 products (finished products)
| Product | Strength | Form · route | Labeler | Application | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|---|
| Celecoxib | Celecoxib 100 mg/1 | CapsuleOral | Northwind Health Company, LLC | ANDA | 51655-059 | 51655-0059-52 | — |
| Celecoxib | Celecoxib 200 mg/1 | CapsuleOral | Northwind Health Company, LLC | ANDA | 51655-060 | 51655-0060-2551655-0060-2651655-0060-52 | — |
| Celecoxib | Celecoxib 200 mg/1 | CapsuleOral | REMEDYREPACK INC. | ANDA | 70518-2233 | 70518-2233-0070518-2233-01 | — |
| Celecoxib | Celecoxib 200 mg/1 | CapsuleOral | A-S Medication Solutions | ANDA | 50090-4789 |
| 50090-4789-0050090-4789-0150090-4789-02 |
| — |
| Celecoxib | Celecoxib 100 mg/1 | CapsuleOral | Bryant Ranch Prepack | ANDA | 71335-1804 | 71335-1804-0171335-1804-0271335-1804-03+4 more | — |
|---|
| Celecoxib | Celecoxib 100 mg/1 | CapsuleOral | Proficient Rx LP | ANDA | 63187-301 | 63187-0301-3063187-0301-6063187-0301-90 | — |
|---|
| Celecoxib | Celecoxib 400 mg/1 | CapsuleOral | Micro Labs Limited | ANDA | 42571-145 | 42571-0145-0542571-0145-60 | — |
|---|
| Celecoxib | Celecoxib 50 mg/1 | CapsuleOral | Micro Labs Limited | ANDA | 42571-142 | 42571-0142-0542571-0142-3042571-0142-33+1 more | — |
|---|
| Celecoxib | Celecoxib 100 mg/1 | CapsuleOral | Micro Labs Limited | ANDA | 42571-143 | 42571-0143-0142571-0143-0542571-0143-30+2 more | — |
|---|
| Celecoxib | Celecoxib 100 mg/1 | CapsuleOral | Direct Rx | ANDA | 72189-123 | 72189-0123-3072189-0123-6072189-0123-71+2 more | — |
|---|
| Celecoxib | Celecoxib 200 mg/1 | CapsuleOral | Micro Labs Limited | ANDA | 42571-144 | 42571-0144-0142571-0144-0542571-0144-29+2 more | — |
|---|
| Celecoxib | Celecoxib 50 mg/1 | CapsuleOral | NIVAGEN PHARMACEUTICALS, INC. | ANDA | 75834-236 | 75834-0236-0575834-0236-1175834-0236-60 | — |
|---|
| Celecoxib | Celecoxib 100 mg/1 | CapsuleOral | NIVAGEN PHARMACEUTICALS, INC. | ANDA | 75834-237 | 75834-0237-0175834-0237-0575834-0237-11 | — |
|---|
| Celecoxib | Celecoxib 200 mg/1 | CapsuleOral | NIVAGEN PHARMACEUTICALS, INC. | ANDA | 75834-238 | 75834-0238-0175834-0238-0575834-0238-11 | — |
|---|
| Celecoxib | Celecoxib 400 mg/1 | CapsuleOral | NIVAGEN PHARMACEUTICALS, INC. | ANDA | 75834-239 | 75834-0239-0575834-0239-1175834-0239-60 | — |
|---|
| Celecoxib | Celecoxib 200 mg/1 | CapsuleOral | Bryant Ranch Prepack | ANDA | 71335-1066 | 71335-1066-0071335-1066-0171335-1066-02+7 more | — |
|---|
| Celecoxib | Celecoxib 100 mg/1 | CapsuleOral | REMEDYREPACK INC. | ANDA | 70518-3424 | 70518-3424-0170518-3424-02 | — |
|---|
| Celecoxib | Celecoxib 100 mg/1 | CapsuleOral | Strides Pharma Science Limited | ANDA | 64380-824 | — | — |
|---|
| Celecoxib | Celecoxib 200 mg/1 | CapsuleOral | PD-Rx Pharmaceuticals, Inc. | ANDA | 43063-669 | 43063-0669-1043063-0669-1443063-0669-20+2 more | — |
|---|
| Celeryapium graveolens | Celery .1 g/mL | Injection, SolutionPercutaneous | ALK-Abello, Inc. | BLA | 0268-6120 | 00268-6120-0600268-6120-10 | — |
|---|
| Celestone Soluspanbetamethasone acetate and betamethasone sodium phosphate | Betamethasone acetate 3 mg/mL; Betamethasone sodium phosphate 3 mg/mL | Injection, SuspensionIntra-articular, Intralesional, Intramuscular, Soft tissue | Sportpharm LLC | NDA | 85766-070 | 85766-0070-05 | — |
|---|
| Celestone Soluspanbetamethasone acetate and betamethasone sodium phosphate | Betamethasone acetate 3 mg/mL; Betamethasone sodium phosphate 3 mg/mL | Injection, SuspensionIntra-articular, Intralesional, Intramuscular, Soft tissue | Organon LLC | NDA | 78206-118 | 78206-0118-01 | — |
|---|
| Celistar Microneedling Infusionhyaluronate sodium | Hyaluronate sodium 3.5 g/100mL + 2 more ingredients | LiquidTopical | Guangdong Outeli Biotechnology Co., Ltd. | OTC monograph drug | 87765-001 | 87765-0001-0187765-0001-02 | — |
|---|
| Celtis Occidentalis Pollenhackberry | Celtis occidentalis pollen .05 g/mL | Injection, SolutionPercutaneous | ALK-Abello, Inc. | BLA | 0268-6626 | 00268-6626-06 | — |
|---|
| Celtis Occidentalis Pollenhackberry | Celtis occidentalis pollen .1 g/mL | Injection, SolutionSubcutaneous | ALK-Abello, Inc. | BLA | 0268-1198 | 00268-1198-50 | — |
|---|
| Celtis Occidentalis Pollenhackberry | Celtis occidentalis pollen .05 g/mL | Injection, SolutionSubcutaneous | ALK-Abello, Inc. | BLA | 0268-1199 | 00268-1199-1000268-1199-50 | — |
|---|
| Cenchris Contortrixagkistrodon contortrix venom | Agkistrodon contortrix venom 200 [kp_C]/200[kp_C] | PelletOral | Boiron | Unapproved homeopathic | 0220-1290 | 00220-1290-41 | — |
|---|
| Centella Relief Soothing Sunscreenavobenzone, homosalate, octisalate, octocrylene | Octocrylene 9 g/100mL + 3 more ingredients | LotionTopical | IUNIK Co., Ltd. | OTC monograph drug | 83403-100 | 83403-0100-02 | — |
|---|
| CENTELLA SUNSCREEN Creamzinc oxide | Zinc oxide .24 g/mL | CreamTopical | Yunqi Cosmetics (Shenzhen) Co., Ltd | OTC monograph drug | 84763-010 | 84763-0010-01 | — |
|---|
| Centrocodeamerican ginseng, adenosine triphosphate, corticotropin, alfalfa, bos taurus hypothalamus, phytolacca americana root, bos taurus pituitary gland posterior, thyroid unspecified, iodine, silicon dioxide, oster shell calcium carbonate crude, strychnos ignatii seed, iridium, lachesis muta venom, lycopodium clavatum spore, sodium chloride, strychnos nux-vomica seed, phosphorus, selenium, uranyl nitrate hexahydrate. | American ginseng 3 [hp_X]/mL + 19 more ingredients | LiquidOral | Natural Creations, Inc. | Unapproved homeopathic | 43406-0124 | 43406-0124-01 | — |
|---|
| Ceo-Twolaxative | Potassium bitartrate .9 g/5.7g; Sodium bicarbonate .6 g/5.7g | SuppositoryRectal | Beutlich Pharmaceuticals, LLC | OTC monograph drug | 0283-1023 | 00283-1023-0200283-1023-3600283-1023-54 | — |
|---|
| Cephalexin | Cephalexin 500 mg/1 | CapsuleOral | Direct_Rx | ANDA | 61919-606 | 61919-0606-20 | — |
|---|
| Cephalexin | Cephalexin 500 mg/1 | CapsuleOral | Direct_Rx | ANDA | 61919-606 | 61919-0606-30 | — |
|---|
| Cephalexin | Cephalexin 500 mg/1 | CapsuleOral | DIRECT RX | ANDA | 61919-606 | 61919-0606-1061919-0606-5661919-0606-60 | — |
|---|
| Ceprotinprotein c concentrate human | — | Kit | Takeda Pharmaceuticals America, Inc. | BLA | 0944-4177 | 00944-4177-05 | — |
|---|
| Ceprotinprotein c concentrate human | — | Kit | Takeda Pharmaceuticals America, Inc. | BLA | 0944-4179 | 00944-4179-10 | — |
|---|
| Cequacyclosporine | Cyclosporine .0009 g/mL | Solution/ dropsOphthalmic, Topical | Sun Pharmaceutical Industries, Inc. | NDA | 47335-506 | 47335-0506-96 | — |
|---|
| Cequacyclosporine | Cyclosporine .0009 mg/mL | Solution/ dropsOphthalmic, Topical | Sun Pharmaceutical Industries, Inc. | NDA | 47335-507 | 47335-0507-97 | — |
|---|
| CERAMIDE LIFT and FIRMoctinoxate, oxybenzone, avobenzone, octisalate, octocrylene | Oxybenzone 5 mg/g + 3 more ingredients | EmulsionTopical | REVLON | OTC monograph drug | 10967-666 | 10967-0666-17 | — |
|---|
| CERAMIDE LIFT and FIRM EYE SPF 15oxybenzone, octinoxate | Octinoxate 4.1 mg/g; Oxybenzone 1.4 mg/g | EmulsionTopical | REVLON | OTC monograph drug | 10967-667 | 10967-0667-61 | — |
|---|
| Ceramide Makeup SPF 15octinoxate, titanium dioxide | Titanium dioxide 3 mg/g; Octinoxate 4 mg/g | CreamTopical | REVLON | OTC monograph drug | 10967-668 | 10967-0668-01 | — |
|---|
| Ceramide Premiere Broad Spectrum SPF 30octinoxate, octisalate, oxybenzone, octocrylene, avobenzone | Oxybenzone 4 mg/g + 4 more ingredients | EmulsionTopical | REVLON | OTC monograph drug | 10967-669 | 10967-0669-17 | — |
|---|
| Cerave Developed With Dermatologists Hydrating Sunscreen SPF 30 Face Lightweight, Non-Greasy Feel 3 Essential Ceramides Niacinamide Mineral Sunscreentitanium dioxide and zinc oxide | Titanium dioxide 60 mg/mL; Zinc oxide 50 mg/mL | LotionTopical | L'Oreal USA Products Inc | OTC monograph drug | 49967-150 | 49967-0150-0149967-0150-0249967-0150-03 | — |
|---|
| CERAVE DEVELOPED WITH DERMOTOLOGISTS Invisible Mineral Sunscreen FOR ALL SKIN TYPES AND TONES FACE UVB AND UVA BROAD SPECTRUM SPF 50titanium dioxide and zinc oxide | Titanium dioxide 26.6 mg/mL; Zinc oxide 153.5 mg/mL | LotionTopical | LOreal USA Products Inc | OTC monograph drug | 82046-894 | 82046-0894-0182046-0894-02 | — |
|---|
| CERAVE Hydrating Mineral Sunscreen Light Sheer Tint Broad Spectrum SPF 30titanium dioxide and zinc oxide | Titanium dioxide 55 mg/mL; Zinc oxide 100 mg/mL | LotionTopical | LOreal USA Products Inc | OTC monograph drug | 49967-589 | 49967-0589-01 | — |
|---|
| Cerebyxfosphenytoin sodium | Fosphenytoin sodium 50 mg/mL | Injection, SolutionIntramuscular, Intravenous | Pfizer Laboratories Div Pfizer Inc | NDA | 0069-5471 | 00069-5471-02 | — |
|---|
| Cerebyxfosphenytoin sodium | Fosphenytoin sodium 50 mg/mL | Injection, SolutionIntramuscular, Intravenous | Pfizer Laboratories Div Pfizer Inc | NDA | 0069-6001 | 00069-6001-2100069-6001-25 | — |
|---|
| Cerebyxfosphenytoin sodium | Fosphenytoin sodium 50 mg/mL | Injection, SolutionIntramuscular, Intravenous | Pfizer Laboratories Div Pfizer Inc | NDA | 0069-5474 | 00069-5474-02 | — |
|---|
| Ceretectechnetium tc-99m exametazime | Technetium tc-99m exametazime .5 mg/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | Medi-Physics Inc. dba GE Healthcare. | NDA | 17156-022 | 17156-0022-05 | — |
|---|
| Ceriannafluoroestradiol f 18 | Fluoroestradiol f-18 100 mCi/mL | InjectionIntravenous | GE Healthcare Inc. | NDA | 72874-001 | 72874-0001-01 | — |
|---|
The FDA’s live API pages through the first 25,000 products of any list. Pick a letter or a filter to reach the rest, or search for a specific product.